AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edasure 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Edaravone (1.5mg)

Overview Edasure 1.5mg Injection

Neuromuscular support provided by the 1.5mg Edasure injection aids in managing amyotrophic lateral sclerosis (ALS), a debilitating neurological condition causing muscle weakness and functional impairment. This antioxidant medication mitigates nerve cell deterioration, potentially slowing disease advancement. Administered intravenously by a healthcare provider—not for self-injection—it's reserved for patients unable to take oral medication. Follow your physician's prescribed dosage and regimen; if a dose is missed, administer it promptly. Commonly reported side effects include headaches, ecchymosis, and gait abnormalities. Injection site reactions (pain, erythema, edema) are possible but typically transient. Persistent or bothersome side effects warrant medical consultation. Report any allergic reactions immediately, including pruritus, facial or lingual swelling, which necessitate urgent medical intervention.

Uses of Edasure 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Edasure 1.5mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.

Common Side effects of Edasure 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edasure 1.5mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

How Edasure 1.5mg Injection works:

Neuro-protective Edasure 1.5mg Injection, an antioxidant, enhances cognitive function and safeguards nerve cells. Its mechanism involves mitigating the neuronal damage inflicted by free radicals, thus delaying ALS symptom onset. This effect is achieved by restoring equilibrium between antioxidants and free radicals, reducing oxidative stress within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Edasure 1.5mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Edasure 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Edasure 1.5mg Injection use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Edasure 1.5mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Edasure 1.5mg Injection's use in individuals with renal impairment. Seek medical advice.

LiverLiverCAUTION

Edasure 1.5mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult your physician. Data regarding Edasure 1.5mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate liver dysfunction.

What if you forget to take Edasure 1.5mg Injection :

NA

Facts to Know About Edasure 1.5mg Injection

LabelValue
Type of Compound Pyrazolone-based compounds
Addictive None.
Medication Classification Nervous system medications
Mechanism of Action Cognitive enhancer

FAQs on Edasure 1.5mg Injection

Edasure 1.5mg Injection may cause side effects such as disorientation, headache, and gait disturbance. Less frequent adverse reactions include skin reactions (rash and pruritus), respiratory distress (shortness of breath, chest constriction, wheezing, cough), particularly in asthmatic individuals, and mycoses.
The injectable formulation of Edasure, 1.5mg, is a solution administered intravenously over a one-hour period by a qualified medical practitioner within a clinical setting. For the initial 28-day treatment cycle, daily injections are typically given for the first fourteen days. Subsequent 28-day cycles involve daily injections during the first ten days. Dosage frequency is determined by the physician, according to individual patient response.
Riluzole 1.5mg injection is indicated for the management of amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease characterized by the gradual deterioration of motor neurons, resulting in muscle atrophy and weakness. Riluzole 1.5mg injection functions by retarding the progression of neuronal damage linked to advancing ALS symptoms.
Consult your physician or pharmacist about any allergies you have, including to edaravone, other drugs, sodium bisulfite, or any component of Edasure 1.5mg Injection. Disclose all current and planned medications, vitamins, and supplements to your doctor before starting treatment. Dosage adjustments or close monitoring for adverse reactions may be necessary. Inform your doctor of any history of asthma, and whether you are pregnant, intend to become pregnant, or are breastfeeding. Contact your doctor immediately if you conceive while undergoing edaravone therapy.
Research has yet to determine whether amyotrophic lateral sclerosis (ALS) is preventable. Nevertheless, understanding associated risk factors may lessen the likelihood of developing the condition. These factors include tobacco use and contact with pesticides and insecticides. Furthermore, evidence indicates a heightened ALS risk among military veterans.
Individuals of Caucasian and non-Hispanic descent exhibit the highest incidence of this disease. Between 5% and 10% of all cases have a familial basis, resulting from inherited genetic predisposition. Onset can occur at any age, though the most frequent presentation is between 55 and 75 years. A slightly higher prevalence is observed in males compared to females; however, this disparity diminishes with increasing age. Research indicates a potential association between military service and a 1.5 to 2-fold increased risk, possibly linked to exposure to toxins during military operations.
Studies propose a link between exposure to toxins in combat or intense physical exertion and a heightened ALS risk among veterans and athletes.
Initial ALS manifestations can involve muscle fasciculations in the limbs or tongue, muscle spasms, muscle rigidity (spasticity), and weakening of arm, leg, neck, or diaphragm muscles. Speech may become unclear and nasal, and swallowing difficulties may arise. The initial symptom for many is hand or arm weakness, hindering everyday actions like fastening buttons, writing, or operating a key. Alternatively, leg weakness can be the first sign, causing gait abnormalities, increased tripping, or stumbling.
Edasure 1.5mg Injection
307
MRP 374
17% off